Company research / CL

Colgate Palmolive Co (CL)

SEC name COLGATE PALMOLIVE CO · CIK 0000021665 · NYSE · Perfumes, Cosmetics & Other Toilet Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Colgate Palmolive Co reported revenue of $20.38B. Revenue grew 1.4% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $21.05B.

Key ratios (year ended 2025-12-31)

60.1%
Gross margin
16.2%
Operating margin
10.5%
Net margin
n/m
Return on year-end equity
1.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-02

Headquarters locality: New York City · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Stock splits: 2-for-1, first reflected in a filing dated 2013-07-25. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$21.05B$20.38B$20.10B$19.46B$17.97B$17.42B$16.47B$15.69B$15.54B$15.45B$15.20B
Cost of Revenue$8.33B$8.13B$7.94B$8.13B$7.72B$7.05B$6.45B$6.37B$6.31B$6.17B$6.07B
Gross Profit$12.72B$12.25B$12.16B$11.33B$10.25B$10.38B$10.02B$9.32B$9.23B$9.28B$9.12B
R&D Expensen/a$366.00M$355.00M$343.00M$320.00M$307.00M$290.00M$281.00M$277.00M$285.00M$289.00M
Operating Income$3.13B$3.31B$4.27B$3.98B$2.89B$3.33B$3.88B$3.55B$3.69B$3.71B$3.96B
Depreciation & Amortization$642.00M$630.00M$605.00M$567.00M$545.00M$556.00M$539.00M$519.00M$511.00M$475.00M$443.00M
EBITDA$3.77B$3.94B$4.87B$4.55B$3.44B$3.89B$4.42B$4.07B$4.21B$4.18B$4.40B
Net Income$2.04B$2.13B$2.89B$2.30B$1.78B$2.17B$2.69B$2.37B$2.40B$2.02B$2.44B
EPS (Diluted)n/a$2.63$3.51$2.77$2.13$2.55$3.14$2.75$2.75$2.28$2.72
Total Assets$16.79B$16.33B$16.05B$16.39B$15.73B$15.04B$15.92B$15.03B$12.16B$12.68B$12.12B
Total Liabilities$16.22B$15.96B$15.50B$15.44B$14.93B$14.07B$14.82B$14.48B$11.96B$12.43B$12.11B
Long-Term Debtn/a$7.84B$7.00Bn/an/an/an/an/a$6.35B$6.57B$6.52B
Shareholders' Equity$236.00M$54.00M$212.00M$609.00M$401.00M$609.00M$743.00M$117.00M-$102.00M-$60.00M-$243.00M
Cash & Equivalents$1.37B$1.29B$1.10B$966.00M$775.00M$832.00M$888.00M$883.00M$726.00M$1.53B$1.31B
Operating Cash Flow$4.46B$4.20B$4.11B$3.75B$2.56B$3.33B$3.72B$3.13B$3.06B$3.05B$3.14B
Capital Expenditures$598.00M$564.00M$561.00M$705.00M$696.00M$567.00M$410.00M$335.00M$436.00M$553.00M$593.00M
Free Cash Flow$3.86B$3.63B$3.55B$3.04B$1.86B$2.76B$3.31B$2.80B$2.62B$2.50B$2.55B
Share Repurchases$1.29B$1.21B$1.74B$1.13B$1.31B$1.32B$1.48B$1.20B$1.24B$1.40B$1.33B
Shares Outstandingn/a801.24M812.57M821.41M830.21M840.48M849.89M854.70M862.91M874.70M883.11M
Dividends Per Sharen/a$2.08$2.48$1.91$1.86$1.79$1.75$1.71$1.66$1.59n/a
Weighted Average Diluted Sharesn/a811.10M823.20M829.20M838.80M848.30M859.30M861.10M873.00M887.80M898.40M
EPS (Basic)n/a$2.64$3.53$2.78$2.13$2.56$3.15$2.76$2.76$2.30$2.74

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView